PerpEquities

Equity · Consumer defensive

Is Colgate-Palmolive (CL) tradable as a perp? Not yet

Colgate-Palmolive makes and sells consumer goods like toothpaste, soap, and pet food under brands such as Colgate and Hill's.

Not yet listed on any perp exchange

No perpetual-futures venue lists CL yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
MDLZTGTMNSTELKRKVUE

Price chart

Interactive TradingView chart

TradingView symbol NYSE:CL

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-10-30 · next report 2027-01-29 · Updated 68h ago
All financials →

Valuation & key figures

Market cap
$77.7B
Updated 68h ago
Revenue
$21.3B
Trailing 12 months
Revenue growth
+5%
Next fiscal year
Profit margin
+9.6%
P/E
37.9
Peer P/E 21.2
P/S
3.6
Peer P/E
21.2
Similar listed perps
Free cash flow
$3.8B
Trailing 12 months
Net income
$2.1B
Trailing 12 months
Revenue estimate
$21.4B
Next fiscal year
Earnings
2027-01-29
Revenue est. $5.4B · Updated 68h ago
Dividend
$0.53
2026-10-20
Revenue (TTM)$21.3B+5.9% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)20.5%-1.1 pp vs a year agoOperating income $4.37B
Net income (TTM)$2.05B-29.4% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$3.79B+10.0% vs a year agoCapex $577M
Diluted EPS (TTM)$2.55-28.5% vs a year agoSum of the last 4 quarters
Net cash-$6.19B+10.9% vs a year agoCash + short-term investments - debt
  • Last report (2026-10-30): revenue beat by 0.6%, EPS beat by 4.8%Revenue $5.37B vs $5.34B expected (+0.6%); EPS $0.97 vs $0.93 (+4.8%).
  • Revenue growth steady: 4.6% year on yearQ3 '26 revenue $5.37B, against an average of 5.3% over the four quarters before.
  • Operating margin 20.5% (TTM), -1.1 pp on a year agoOperating income grew 0.6% while revenue grew 5.9%.
  • 47.3% of pre-tax profit is eaten by non-operating lossesPre-tax income $2.97B vs operating income $4.37B (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.

Revenue, operating income and growth

quarterly

Revenue by business line

latest quarter
LineRevenuey/yShare
Oral, Personal and Home Care$4.16B+4.4%100.0%
Pet Nutrition–––
Hill's Pet Nutrition–––
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 279 lines Colgate-Palmolive Company reported to the SEC

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20263.88$21.4B+5%10
FY 20274.08$22B+8%12
FY 20284.38$22.7B+12%6
FY 20294.58$23.4B+15%3
FY 20304.76$24.1B+18%2
Q1 20270.98$5.5B+2%10

Company events

6
2027-01-29EarningsActual - / Estimate 0.97-
2026-10-30Earnings · Before market openActual 0.97 / Estimate 0.93Beat
2026-10-20Dividend$0.53-
2026-07-31EarningsActual 0.99 / Estimate 0.95Beat
2026-07-20Dividend$0.53-
2026-05-01EarningsActual 0.97 / Estimate 0.94Beat

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
MDLZ$82.2B2.120.4+10.2%1TGT$71.5B0.716.3+4.1%3MNST$94.1B10.244.1+23.1%3EL$39.5B2.6106.7+2.4%2KR$39.4B0.336.1+0.7%1KVUE$37.1B2.421.9+10.9%1KMB$36.7B2.211.1+19.9%2MO$129.8B6.116.1+38.1%6

Analyst track record

How the analysts covering CL have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings114345
Analysts1931
Buy / hold / sell75 / 38 / 1215 / 119 / 11
Upgrades / downgrades / initiations5 / 2 / 19 / 8 / 6
Price targets hit / missed42 / 70 (38%)117 / 212 (36%)
Avg. return after a rating (TipRanks)-1.4%-2.6%
Best / worst call+21.0% / -15.3%+24.2% / -23.6%

After buy calls on this stock: median 21-day move +2.5% vs S&P 500 -0.7% (n = 220)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Christopher CareyWells Fargo100% hit rate on this stock · 11 targets measuredHoldtarget $95.00Nov 2, 2026
  2. Andrea Faria TeixeiraJ.P. Morgan63% hit rate on this stock · 19 targets measuredBuytarget $102Nov 2, 2026
  3. Dara MohsenianMorgan Stanley58% hit rate on this stock · 19 targets measuredBuytarget $111Nov 1, 2026

Latest ratings

DateAnalystCallTarget
Nov 3, 2026Unknown AnalystBernsteinHoldMaintained$98.00article ↗
Nov 3, 2026Lauren LiebermanBarclaysHoldMaintained$95.00article ↗
Nov 3, 2026Unknown AnalystBernsteinHoldMaintained$98.00
Nov 2, 2026Kevin GrundyExane BNP ParibasBuyMaintained$108article ↗
Nov 2, 2026Nik ModiRBC CapitalBuyReiterated$105article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$80.00$85.00$90.00$95.00$100Dec 25 · Buy 11 · Hold 6 · Sell 1Dec 25Jan 26 · Buy 12 · Hold 6 · Sell 0Feb 26 · Buy 12 · Hold 7 · Sell 0Feb 26Mar 26 · Buy 13 · Hold 6 · Sell 0Apr 26 · Buy 11 · Hold 6 · Sell 0Apr 26May 26 · Buy 11 · Hold 6 · Sell 0Jun 26 · Buy 11 · Hold 7 · Sell 0Jun 26Jul 26 · Buy 11 · Hold 7 · Sell 0Aug 26 · Buy 11 · Hold 7 · Sell 0Aug 26Sep 26 · Buy 11 · Hold 8 · Sell 0Oct 26 · Buy 10 · Hold 6 · Sell 0Oct 26Nov 26 · Buy 10 · Hold 6 · Sell 0Dec 25 · avg. target $87.88Jan 26 · avg. target $89.71Feb 26 · avg. target $96.22Mar 26 · avg. target $96.89Apr 26 · avg. target $94.58May 26 · avg. target $96.00Jun 26 · avg. target $96.00Jul 26 · avg. target $97.94Aug 26 · avg. target $98.82Sep 26 · avg. target $98.78Oct 26 · avg. target $99.27Nov 26 · avg. target $99.27Dec 25 · month-end close $79.02Jan 26 · month-end close $90.29Feb 26 · month-end close $99.14Mar 26 · month-end close $85.23Apr 26 · month-end close $85.36May 26 · month-end close $90.13Jun 26 · month-end close $91.68Jul 26 · month-end close $91.30Aug 26 · month-end close $89.82Sep 26 · month-end close $85.32Oct 26 · month-end close $95.29Nov 26 · month-end close $95.29

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Nov 3, 2026 · 114 ratings